FDG positron emission tomography/computed tomography scan may identify mantle cell lymphoma patients with unusually favorable outcome.
about
Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agentsMantle cell lymphoma: observation to transplantationRecent Trends in PET Image Interpretations Using Volumetric and Texture-based Quantification Methods in Nuclear Oncology.Positron Emission Tomography (PET) in OncologyInitial therapy of mantle cell lymphomaA new dimension of FDG-PET interpretation: assessment of tumor biology.Role of PET in lymphoma.FDG PET/CT imaging as a biomarker in lymphoma.Using positron emission tomography to assess tumor proliferation in non-Hodgkin lymphoma.Post-treatment (not interim) positron emission tomography-computed tomography scan status is highly predictive of outcome in mantle cell lymphoma patients treated with R-HyperCVAD.Is there a role for therapy response assessment with 2-[fluorine-18] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in mantle cell lymphoma?Smoldering mantle cell lymphoma.SUV navigator enables rapid [18F]-FDG PET/CT image interpretation compared with 2D ROI and 3D VOI evaluations.Interim positron emission tomography scan associated with international prognostic index and germinal center B cell-like signature as prognostic index in diffuse large B-cell lymphoma.Evaluating the Predictive Ability of Initial Staging F-18 FDG PET/CT for the Prognosis of Non-Hodgkin Malignant Lymphoma Patients Who Underwent Stem Cell Transplantation
P2860
Q28075606-13ECBC28-166E-4678-9B92-92090B7E8E86Q28256317-ECED9C7F-855B-44AB-9492-14B142D382B6Q33669828-D3787151-3FED-4127-8EA9-2F33598A09E5Q34774840-23B9BBCB-AD2B-47C5-8A68-D724254C39ACQ36612648-28E6A233-C295-4415-9222-F7516863DC9FQ37827752-8EB82CA4-B48D-4B45-BD5A-04CABE51DE30Q38195220-E782E895-B18C-49E0-A504-BBEFFEBEE05AQ38312367-6804EB7B-F6EB-4E36-A4A9-F8A704DD5B71Q43206342-0BCD121D-1D93-4944-BE8A-9B403F7BEA28Q44872919-9E1D23F5-6705-40F9-89EA-8C5925956287Q44993089-AD38113E-8144-4A1E-8BC6-B1052E92B4ACQ47111277-EE34FA82-12E0-4A40-B6A2-BAD48097B76EQ50653457-62D210BB-B76A-4B33-8712-86ABEF0C5713Q53210229-52A385A9-585D-432E-AC9F-CB7541F6A06BQ56546435-69AEFE32-61B3-4F56-A6DC-353A5560D6C6
P2860
FDG positron emission tomography/computed tomography scan may identify mantle cell lymphoma patients with unusually favorable outcome.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
FDG positron emission tomograp ...... h unusually favorable outcome.
@en
FDG positron emission tomograp ...... h unusually favorable outcome.
@nl
type
label
FDG positron emission tomograp ...... h unusually favorable outcome.
@en
FDG positron emission tomograp ...... h unusually favorable outcome.
@nl
prefLabel
FDG positron emission tomograp ...... h unusually favorable outcome.
@en
FDG positron emission tomograp ...... h unusually favorable outcome.
@nl
P2093
P1476
FDG positron emission tomograp ...... h unusually favorable outcome.
@en
P2093
Ching-yee Oliver Wong
Felix M Mottaghy
Gregor E Verhoef
Kevin Irish
Lieselot M Brepoels
Maroun Karam
Paul J Feustel
Sigrid G Stroobants
Surya Chundru
P304
P356
10.1097/MNM.0B013E32832E0C13
P577
2009-10-01T00:00:00Z